Biotech Top Losers: TESARO Inc. (NASDAQ:TSRO), Dyax Corp. (NASDAQ:DYAX), Regulus Therapeutics (NASDAQ:RGLS), Cara Therapeutics (NASDAQ:CARA)

Tesaro Inc. (NASDAQ:TSRO) announced Thursday morning that it has entered into an exclusive, worldwide license agreement and immuno-oncology antibody collaboration with AnaptysBio Inc. TESARO Inc. (NASDAQ:TSRO) stock performance was -5.40% in last session and finished the day at $36.76. Traded volume was 732,104.00 shares in the last session and the average volume of the stock remained 469,070.00 shares. TESARO Inc. (NASDAQ:TSRO) insider ownership is 21.88%.

Dyax Corp. (NASDAQ:DYAX) on Mar. 14 announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock, offered at a price to the public of $9.25 per share. Dyax Corp. (NASDAQ:DYAX) dropped -9.11% to $9.23 yesterday on volume of 4.75 million shares. The intra-day range of the stock was $8.94 – $9.30. Dyax Corp. (NASDAQ:DYAX) has a market capitalization of 1.10 billion.

Regulus Therapeutics (NASDAQ:RGLS) had its price target increased by Needham & Company to $14.00 in a research report sent to investors on Friday morning, Analyst Ratings News reports. Regulus Therapeutics Inc. (NASDAQ:RGLS)’s stock on March 14, 2014 reported a lower of -5.02% to the closing price of $10.22. Its fifty two weeks range is $5.83 – $12.89. The total market capitalization recorded 427.36 million. The overall volume in the last trading session was 108,812.00 shares. In its share capital, Regulus Therapeutics Inc. (NASDAQ:RGLS) has 41.82 million outstanding shares.

Equities researchers at Needham & Company LLC assumed coverage on shares of Cara Therapeutics (NASDAQ:CARA) in a research report issued on Thursday, Analyst Ratings reports. The firm set a “buy” rating on the stock. On Friday, shares of Cara Therapeutics Inc. (NASDAQ:CARA) dropped -6.35% to close the day at $17.26. Company return on investment (ROI) is 11.50%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone